Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotype change in vitro and neointimal formation in vivo

Journal of Vascular Surgery

Volumn 28, Issue 2, 1998, Pages 308-318

  Bingley, J A ^a   Hayward, I P ^a   Campbell, J H ^a   Campbell, G R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; POLOXAMER; PROTEOCHONDROITIN SULFATE; PROTEOHEPARAN SULFATE; THYMIDINE; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON CATHETER; CAROTID ARTERY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; MYOFILAMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0031849584     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(98)70167-3     Document Type: Article

References (45)

1. AH Gerschlick DP de Bono Restenosis after angioplasty Br Heart J 64 1990 351 353
2. AJ Brady JB Warren Angioplasty and restenosis BMJ 303 1991 729 730
3. JS Forrester M Fishbein R Helfant J Fagin A paradigm for restenosis based on cell biology: clues for the development of new preventative therapies J Am Coll Cardiol 17 1991 758 769
4. P Libby D Schwartz E Brogi H Tanaka S Clinton A cascade model for restenosis Circulation 86 Suppl III 1992 III-47 III-52
5. GR Campbell JH Campbell Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis Exp Mol Pathol 42 1985 139 162
6. JH Chamley-Campbell GR Campbell R Ross Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens J Cell Biol 89 1981 379 383
7. JH Campbell RE Rennick SG Kalevitch GR Campbell Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype Exp Cell Res 200 1992 156 167
8. DM Templeton Proteoglycans in cell regulation Crit Rev Clin Lab Sci 29 1992 141 184
9. A Clowes MJ Karnovsky Suppression by heparin of smooth muscle cell proliferation in injured arteries Nature 265 1977 625 626
10. WE Benitz RT Kelley CM Anderson DE Lorant M Bernfield Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation Am J Respir Cell Mol Biol 2 1990 13 24
11. A Schmidt E Buddecke Bovine aortic smooth muscle cells synthesize two functionally different proteoheparan sulfate species Exp Cell Res 89 1990 269 275
12. ZS Galis MZ Alavi S Moore Sulfated proteoglycans of rabbit aorta: selective extraction and alternative method for glycosaminoglycan moiety analysis Analyt Biochem 204 1992 390 397
13. T Bitter HM Muir A modified uronic acid carbazole reaction Analyt Biochem 4 1962 330 334
14. OH Lowry NJ Rosebrough AL Farr RJ Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
15. HJ Moller D Heinegard JH Poulsen Combined Alcian blue and silver staining of subnanogram quantities of proteoglycans and glycosaminoglycans in sodium dodecyl sulfate-polyacrylamide gels Analyt Biochem 209 1993 169 175
16. JA Manderson PRL Mosse JA Safstrom SB Young GR Campbell Balloon catheter injury to the rabbit carotid artery. I. Changes in smooth muscle cell phenotype Arterioscler Thromb 9 1989 289 298
17. M Simons ER Edelman JL DeKeyser R Langer RD Rosenberg Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo Nature 359 1992 67 70
18. JH Campbell O Kocher O Skalli G Gabbiani GR Campbell Cytodifferentiation and expression of α-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells Arteriosclerosis 9 1989 633 643
19. A Schmidt E Buddecke Cell-associated proteoheparan sulfate from bovine arterial smooth muscle cells Exp Cell Res 178 1988 242 253
20. KA Fults TP Johnston Sustained-release of urease from a poloxamer gel matrix J Parenter Sci Technol 44 1990 58 65
21. C Rogers MJ Karnovsky ER Edelman Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration Circulation 88 1993 1215 1221
22. ER Edelman MJ Karnovsky Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis Circulation 89 1994 770 776
23. JW Currier TK Pow CC Haudenschild AC Minihan DP Faxon Low molecular weight heparin (Enoxaparin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit J Am Coll Cardiol 17 1991 118B 125B
24. ER Edelman DH Adams MJ Karnovsky Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury Proc Natl Acad Sci USA 87 1990 3773 3777
25. T Okada DH Bark MR Mayberg Localized release of perivascular heparin inhibits intimal proliferation after endothelial injury without systemic anticoagulation Neurosurgery 25 1989 892 898
26. U Lindahl M Kusche K Lidholt L-G Oscarrson Biosynthesis of heparin and heparan sulfate DA Lane U Lindahl Heparin 1989 Arnold London 548 574
27. TN Wight Cell biology of arterial proteoglycans Arterioscler Thromb 9 1989 1 20
28. M Bernfield R Kokenyesi M Kato Biology of the syndecans Annu Rev Cell Biol 8 1992 365 393
29. JT Gallagher JE Turnbull M Lyon Patterns of sulphation in heparan sulphate: polymorphism based on a common structural theme Int J Biochem 24 1992 553 560
30. W Volker A Schmidt E Buddecke Mapping of proteoglycans in human arterial tissue Eur J Cell Biol 45 1987 72 79
31. W Volker A Schmidt W Oortmann T Broszey V Faber E Buddecke Mapping of proteoglycans in atherosclerotic lesions Eur Heart J 11 Suppl E 1990 29 40
32. ST Nikkari HT Jarvelainen TN Wight M Ferguson AW Clowes Smooth muscle cell expression of extracellular matrix genes after arterial injury Am J Pathol 144 1994 1348 1356
33. G Cizmeci-Smith E Langan J Youkey LJ Showalter DJ Carey Syndecan-4 is a primary-response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells Arterioscler Thromb Vasc Biol 17 1997 172 180
34. JJ Castellot ML Addonizio R Rosenberg MJ Karnovsky Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth J Cell Biol 90 1981 372 379
35. JD San Antonio MJ Karnovsky ME Ottlinger R Schillig LA Pukac Isolation of heparin-insensitive aortic smooth muscle cells: growth and differentiation Arterioscler Thromb 13 1993 748 757
36. L Capron J Jarnet D Heudes D Joseph-Monrose P Bruneval Repeated balloon injury of rat aorta: a model of neointima with attenuated inhibition by heparin Arterioscler Thromb Vasc Biol 17 1997 1649 1656
37. J Yahalom A Eldor Z Fuks I Vlodavsky Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase J Clin Invest 74 1984 1842 1849
38. Y Matzner M Bar-ner J Yahalom R Ishai-Michaeli Z Fuks I Vlodavsky Degradation on heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils J Clin Invest 76 1985 1306 1313
39. K Shimada T Ozawa Subendothelial extracellular-matrix heparan sulfate proteoglycan-degrading activity of human monocyte macrophages Heart Vessels 3 1987 175 181
40. G Cizmeci-Smith RC Stahl LJ Showalter DJ Carey Differential expression of transmembrane proteoglycans in vascular smooth muscle cells J Biol Chem 268 1993 18740 18747
41. J Saltis AC Thomas A Agrotis JH Campbell GR Campbell A Bobik Expression of growth factor receptors on arterial smooth muscle cells: dependency on cell phenotype and serum factors Atherosclerosis 118 1995 77 87
42. G David A Danneels J Duerr Heparan-sulfate proteoglycans: essential co-factors in receptor-mediated processes with relevance to the biology of the vascular wall Atherosclerosis 118 Suppl 1995 S57 S67
43. A Skaletz-Rorowski A Schmidt G Breithardt E Buddecke Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells Arterioscler Thromb Vasc Biol 16 1996 1063 1069
44. MJ Brack A Chauhan J Fox The Subcutaneous Heparin and Angioplasty Restenosis Prevention (SHARP) trial: results of a multicenter randomized trial investigating the effects of high dose unfractionated heparin on angiographic restenosis and clinical outcome J Am Coll Cardiol 26 1995 947 954
45. KG Lehmann RJ Doria JM Feuer JX Hall DT Hoang Paradoxical increase in restenosis rate with chronic heparin use J Am Coll Cardiol 17 1991 181A